Elastomeric Closures Market Worth USD 9.3 billion by 2030 | Roots Analysis


Posted August 27, 2020 by charlottefraser21

The Elastomeric Closures Market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis

 
Roots Analysis has done a detailed study on Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

Key Market Insights
• The elastomeric container closures market is fragmented, featuring the presence of a large number of established players; a relatively larger proportion of small-sized players are based in developing geographies
• Currently, there are over 240 closures, fabricated using a variety of elastomeric materials, available for use in parenteral primary packaging containers; majority of these products are available in the ready-to-use format
• Over time, companies have established preferences regarding fabrication materials for container-closure systems for different drug classes in order to ensure that their products are free from chemical impurities
• A number of conferences related to pharmaceutical packaging have been organized in the recent past; in addition, stakeholders have also entered into strategic agreements to strengthen their product portfolios
• In order to cope up with emerging trends in the pharmaceutical packaging market, it is important for container closure manufacturers to improve existing practices to cater to the changing needs of drug developers
• The global demand for elastomeric closures is presently driven by rising adoption of parenteral containers; in future, pre-sterilized and coated closures are anticipated to drive the demand at a relatively faster pace
• The overall market is poised to grow steadily; the opportunity is likely to be well-distributed across various types of containers, types of closures and regions

Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Types of Pharmaceutical Packaging
3.2.2. Innovation in Pharmaceutical Packaging
3.2.3. Traditional Aseptic Pharmaceutical Filling Operations
3.2.4. Limitations of Traditional Primary Packaging
3.3. Role of Containers-Closures Systems in Pharmaceutical Packaging
3.4. Types of Closures Used in Pharmaceutical Packaging
3.4.1. Closures for Prefilled Syringes / Syringes
3.4.2. Closures for Vials
3.4.3. Closures for Cartridges
3.5. Key Considerations for Choosing Materials for Fabricating Closures
3.6. Elastomeric Packaging Materials
3.6.1. Key Properties of Elastomeric Packaging Materials
3.6.2. Popular Types of Elastomeric Packaging Materials
3.6.3. Regulatory Guidelines for Elastomeric Closures
3.6.4. Manufacturing Process for Elastomeric Closures
3.6.5. Quality Assessment Tests for Elastomeric Closures
3.6.6. Advantages and Limitations of Elastomeric Packaging Materials
3.7. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Elastomeric Closures for Parenteral Containers: List of Products
4.2.1. Analysis by Type of Closure
4.2.1.1. Analysis by Type of Closure and Headquarters of Manufacturer
4.2.1.2. Analysis by Type of Closure and Size of Player
4.2.2. Analysis by Type of Container
4.2.3. Analysis by Type of Elastomeric Material
4.2.4. Analysis by Drug Class
4.2.5. Analysis by Sterilization Status
4.2.6. Analysis by Sterilization Technique
4.2.7. Analysis by Type of Coating
4.3. Elastomeric Closures for Parenteral Containers: List of Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Target Market
4.3.5. Analysis by Scale of Production
4.3.6. Leading Manufacturers: Analysis by Number of Products
4.3.7. Manufacturer Landscape: Analysis by Company Size and Location of Headquarters
4.4. Elastomeric Closures for Parenteral Containers: Recent Initiatives of Players
4.5. Concluding Remarks

5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Key Players Based in North America
5.2.1. Aptar Pharma (a Part of AptarGroup)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Product Portfolio
5.2.1.4. Recent Developments and Future Outlook
5.2.2. DWK Life Sciences
5.2.2.1. Company Overview
5.2.2.2. Product Portfolio
5.2.2.3. Recent Developments and Future Outlook
5.2.3. West Pharmaceutical Services
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Product Portfolio
5.2.3.4. Recent Developments and Future Outlook
5.3. Key Players Based in Europe
5.3.1. Datwyler Sealing Solutions (a Part of Datwyler Group)
5.3.1.1. Company Overview
5.3.1.2. Financial Information
5.3.1.3. Product Portfolio
5.3.1.4 Recent Developments and Future Outlook
5.3.2. Lonstroff (a Part of Sumitomo Rubber Industries)
5.3.2.1. Company Overview
5.3.2.2. Financial Information
5.3.2.3. Product Portfolio
5.3.2.4. Recent Developments and Future Outlook
5.3.3. Ompi (a Part of Stevanato Group)
5.3.3.1. Company Overview
5.3.3.2. Product Portfolio
5.3.3.3. Recent Developments and Future Outlook
5.4. Key Players Based in Asia-Pacific
5.4.1 Daikyo Seiko
5.4.1.1. Company Overview
5.4.1.2. Product Portfolio
5.4.1.3. Recent Developments and Future Outlook
5.4.2. Hebei First Rubber Medical Technology (a Part of DESHENG Group)
5.4.2.1. Company Overview
5.4.2.2. Product Portfolio
5.4.2.3. Recent Developments and Future Outlook
5.4.3. Jiangsu Hualan New Pharmaceutical Material
5.4.3.1. Company Overview
5.4.3.2. Product Portfolio
5.4.3.3. Recent Developments and Future Outlook

6. PACKAGING TRENDS ANALYSIS FOR RECENTLY APPROVED DRUGS
6.1. Chapter Overview
6.2. List of Approved Drugs (2014-2018)
6.2.1. Analysis by Year of Approval
6.2.2. Analysis by Type of Molecule
6.2.3. Analysis by Type of Biologic
6.2.4. Analysis by Holding Temperature Range
6.2.5. Analysis by Type of Container
6.2.6. Analysis by Type of Container and Year of Approval
6.2.7. Analysis by Type of Container and Type of Molecule
6.2.8. Analysis by Type of Container and Dosage Form
6.2.9. Analysis by Type of Container and Route of Administration
6.2.10. Analysis by Type of Container and Holding Temperature Range
6.2.11. Popular Type of Material Used for Containers
6.2.12. Analysis by Type of Closure
6.2.13. Analysis by Type of Closure and Year of Approval
6.2.14. Analysis by Type of Closure and Type of Molecule
6.2.15. Analysis by Type of Closure and Dosage Form
6.2.16. Analysis by Type of Closure and Route of Administration
6.2.17. Analysis by Type of Closure and Holding Temperature Range
6.2.18. Popular Type of Material Used for Closures
6.2.19. Analysis by Type of Elastomeric Material Used for Closures and Dosage Form
6.2.20. Analysis by Type of Elastomeric Material Used for Closures and Route of Administration
6.2.21. Analysis by Type of Elastomeric Material Used for Closures and Holding Temperature Range
6.2.22. Analysis by Type of Elastomeric Material Used for Closures
6.2.23. Most Active Players: Analysis by Number of Drugs Packaged Using Elastomeric Closures
6.2.24. Concluding Remarks

7. RECENT DEVELOPMENTS
7.1. Chapter Overview
7.2. Pharmaceutical Packaging Industry: Partnership Activity
7.2.1. Partnership Models
7.2.2. List of Partnerships and Collaborations
7.2.2.1. Analysis by Year of Partnership
7.2.2.2. Analysis by Type of Partnership
7.2.2.3. Analysis by Focus Area
7.2.2.4. Most Active Players: Analysis by Number of Partnerships
7.3. Elastomeric Container Closures in Pharmaceutical Packaging Industry: Recent Expansions
7.4. Pharmaceutical Packaging Industry: Recent Conferences
7.4.1. List of Recent Conferences
7.4.1.1. Analysis by Year of Occurrence
7.4.1.2. Analysis by Geography
7.4.2. Elastomeric Container Closures: List of Recent Conferences
7.4.2.1. Analysis by Focus Area / Agenda
7.4.3. Geographical Mapping of Conferences
7.5. Concluding Remarks

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis
Phone 1 (415) 800 3415
Business Address Sacramento Los Angeles Beverly Hills 94209
Country United States
Categories Business , Industry , Medical
Tags Elastomeric Closures Market , Elastomeric Closures Market Trends , Elastomeric Closures Market Size
Last Updated August 27, 2020